Penserra Capital Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-89
| Closed | -$233K | – | 1261 |
|
|
2022
Q2 | $233K | Sell |
89
-8
| -8% | -$20.9K | 0.01% | 653 |
|
|
2022
Q1 | $235K | Buy |
97
+14
| +17% | +$33.9K | 0.01% | 688 |
|
|
2021
Q4 | $521K | Buy |
83
+16
| +24% | +$100K | 0.01% | 528 |
|
|
2021
Q3 | $624K | Buy |
67
+40
| +148% | +$373K | 0.01% | 454 |
|
|
2021
Q2 | $273K | Buy |
+27
| New | +$273K | 0.01% | 582 |
|